February 7, 2007

FDA's chief medical officer to speak at Purdue

WEST LAFAYETTE, Ind. - Janet Woodcock, the chief medical officer of the Food and Drug Administration, will speak at Purdue on Thursday (Feb. 8) and Friday (Feb. 9) as the visiting lecturer for the annual Varro E. Tyler Distinguished Lectureship.

Woodcock, who held the position of deputy commissioner and chief operating officer before assuming her current position, will present two lectures during her visit. Both events are free and open to the public.

Her first lecture, titled "Current Direction in Drug Regulation," will be presented at 5 p.m. in Stewart Center's Fowler Hall. A reception will follow in Stewart Center, Room 218 ABC.

Her second lecture, titled "Advancing the Science of Pharmaceutical Quality," will be given during a breakfast reception on Friday (Feb. 9) in the East and West Faculty lounges of the Purdue Memorial Union. Woodcock's lecture will begin at 10 a.m. following the 9 a.m. breakfast.

Woodcock also has served the FDA as director of the Center for Drug Evaluation and Research and as director of the Office of Therapeutics Research and Review for the Center for Biologics Evaluation and Research. She currently collaborates with the commissioner and shares responsibility for the oversight and evaluation of medical and scientific regulatory activities in order to achieve the mission of the FDA.

Woodcock introduced the concept of pharmaceutical risk management as a new approach to drug safety and leads the "Pharmaceutical Quality for the 21st Century Initiative," which aims to modernize pharmaceutical manufacturing and its regulation.

Woodcock also leads the FDA's Critical Path initiative, which is designed to improve the scientific basis for medical product development.

The FDA has awarded Woodcock six Commissioner's Special Citations awards. She also has received the Presidential Rank Meritorious Executive Award and the American Medical Association's Nathan Davis Award.

Woodcock received her medical degree from Northwestern University Medical School and received her bachelor's degree from Bucknell University. She has held teaching appointments at Pennsylvania State University and the University of California at San Francisco.

The lecture series is named in honor of the late Varro E. Tyler, Purdue's Lilly Distinguished Professor of Pharmacognosy in the School of Pharmacy and Pharmaceutical Sciences and former dean and executive vice president for academic affairs for the university.

Tyler is known for his contributions to the advancement of pharmacology, and he authored more than 240 scientific articles, 16 books and a major textbook on pharmacognosy.

Eli Lilly and Co. and Purdue's Department of Industrial and Physical Pharmacy are sponsoring the event.

Writer: Elizabeth Gardner, (765) 494-2081, ekgardner@purdue.edu

Source: Dana Neary, manager of alumni relations and special events for the school of pharmacy and pharmaceutical sciences, (765) 494-2632, nearyd@purdue.edu

Purdue News Service: (765) 494-2096; purduenews@purdue.edu

Related Web site:
Purdue School of Pharmacy and Pharmaceutical Sciences: https://www.pharmacy.purdue.edu

To the News Service home page

Newsroom Search Newsroom home Newsroom Archive